Log in

BATS:IBHDiShares iBonds 2024 Term High Yield and Income ETF Stock Price, Forecast & News

$23.24
+0.08 (+0.35 %)
(As of 06/4/2020 01:47 AM ET)
Add
Today's Range
$23.24
Now: $23.24
$23.34
50-Day Range
$21.96
MA: $22.47
$23.20
52-Week Range N/A
Volume15,000 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 1.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.28 out of 5 stars


Basic Details

Issuer iShares
Fund NameiShares iBonds 2024 Term High Yield and Income ETF
Tax ClassificationRegulated Investment Company
SymbolBATS:IBHD
Inception Date5/7/2019
Fund ManagerJames Mauro, Scott Radell
WebN/A
PhoneN/A

Fund Focus

Asset ClassFixed Income
BenchmarkBloomberg Barclays 2024 Term High Yield and Income Index
CategoryCorporate
FocusBroad Debt
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$9.17 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.35%
Other Expenses0.00%
Total Expenses0.35%
Fee Waiver0.00%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market Maker

Receive IBHD News and Ratings via Email

Sign-up to receive the latest news and ratings for IBHD and its competitors with MarketBeat's FREE daily newsletter.

Geographic Exposure of iShares iBonds 2024 Term High Yield and Income ETF (BATS:IBHD)
Currency Exposure of iShares iBonds 2024 Term High Yield and Income ETF (BATS:IBHD)
Sector Exposure of iShares iBonds 2024 Term High Yield and Income ETF (BATS:IBHD)
Industry Exposure of iShares iBonds 2024 Term High Yield and Income ETF (BATS:IBHD)

iShares iBonds 2024 Term High Yield and Income ETF (BATS:IBHD) Frequently Asked Questions

How has iShares iBonds 2024 Term High Yield and Income ETF's stock been impacted by COVID-19 (Coronavirus)?

iShares iBonds 2024 Term High Yield and Income ETF's stock was trading at $23.49 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IBHD stock has decreased by 1.1% and is now trading at $23.2352. View which stocks have been most impacted by Coronavirus.

Has iShares iBonds 2024 Term High Yield and Income ETF been receiving favorable news coverage?

News stories about IBHD stock have been trending very negative this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. iShares iBonds 2024 Term High Yield and Income ETF earned a daily sentiment score of -3.1 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutiShares iBonds 2024 Term High Yield and Income ETF.

What is iShares iBonds 2024 Term High Yield and Income ETF's stock symbol?

iShares iBonds 2024 Term High Yield and Income ETF trades on the BATS under the ticker symbol "IBHD."

How do I buy shares of iShares iBonds 2024 Term High Yield and Income ETF?

Shares of IBHD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is iShares iBonds 2024 Term High Yield and Income ETF's stock price today?

One share of IBHD stock can currently be purchased for approximately $23.24.

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.